FPMI Financials Monday, July 14, 2014 11:04:18 PM

FPMI Financials Monday, July 14, 2014 11:04:18 PM
FluoroPharma Medical, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 1,313 1,423 641 45
Sales, General and Admin. 3,050 2,726 2,590 807
Non-Recurring Items - - - -
Other - - 41 41
Operating Income (4,362) (4,150) (3,272) (893)
Income From Continuing Operations
Add'l Income/Expense Items (1,194) 133 125 (
Earnings Before Interest and Tax (5,556) (4,017) (3,147) (901)
Interest Expense 51 - 113 53
Earnings Before Tax (5,607) (4,017) (3,260) (954)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,607) (4,017) (3,260) (954)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,607) (4,017) (3,260) (954)
Preferred Stock and Other Adjustments (1,677) (168) (977) -
Net Income Applicable to Common Shareholders (7,284) (4,185) (4,238) (954)